102 related articles for article (PubMed ID: 8240373)
1. Detection of K-ras codon 12 mutation by polymerase chain reaction and differential dot-blot hybridization in sodium saccharin-treated human RSA cell.
Suzuki H; Suzuki N
Biochem Biophys Res Commun; 1993 Oct; 196(2):956-61. PubMed ID: 8240373
[TBL] [Abstract][Full Text] [Related]
2. Suppression of saccharin-induced mutagenicity by interferon-alpha in human RSa cells.
Suzuki N; Suzuki H
Cancer Res; 1995 Oct; 55(19):4253-6. PubMed ID: 7671231
[TBL] [Abstract][Full Text] [Related]
3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
5. Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
Paranavitana CM
Mol Cell Probes; 1998 Oct; 12(5):309-15. PubMed ID: 9778456
[TBL] [Abstract][Full Text] [Related]
6. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections.
Chewawiwat N; Lulitanond V; Nimmanahaeminda K; Thamprasert K; Nicomrat D; Ponglikitmongkol M
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():329-32. PubMed ID: 8629136
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
8. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
9. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
Stratton MR; Fisher C; Gusterson BA; Cooper CS
Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
11. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes in multiple myeloma: point mutation of N-ras.
Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
[TBL] [Abstract][Full Text] [Related]
14. Absence of point mutation of N-ras oncogene in bone marrow cells with aplastic anemia.
Shinohara K; Yujiri T; Kamei S; Ayame H; Tanaka M; Ando S; Tajiri M
Int J Cell Cloning; 1992 Mar; 10(2):94-8. PubMed ID: 1545154
[TBL] [Abstract][Full Text] [Related]
15. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
17. Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation.
Ronai Z; Minamoto T
Hum Mutat; 1997; 10(4):322-5. PubMed ID: 9338587
[TBL] [Abstract][Full Text] [Related]
18. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
Lehman TA; Scott F; Seddon M; Kelly K; Dempsey EC; Wilson VL; Mulshine JL; Modali R
Anal Biochem; 1996 Aug; 239(2):153-9. PubMed ID: 8811898
[TBL] [Abstract][Full Text] [Related]
20. Studies on ras oncogene activation in endometrial carcinoma.
Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]